Jean-Philippe Metges
Overview
Explore the profile of Jean-Philippe Metges including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1998
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lecomte T, Giraudeau B, Phelip J, Tournigand C, Ducreux M, Tougeron D, et al.
Dig Liver Dis
. 2025 Mar;
PMID: 40044552
Bevacizumab shows inter-individual pharmacokinetic variability, with an exposure-response relationship in metastatic colorectal cancer (mCRC) patients. This study explores whether a double dose of bevacizumab, compared to a standard dose, increases...
2.
Thereaux J, Badic B, Fuchs B, Leven C, Caillard A, Lacut K, et al.
Surgery
. 2025 Feb;
181:109171.
PMID: 39952022
Background: Venous thromboembolism is a well-recognized complication after hepatopancreatobiliary surgery. However, there is a paucity of nationwide data on risk factors and incidence within 1 year of surgery in patients...
3.
Nguyen V, Metges J, Morjani M, Pourreau P, Dhamelincourt E, Queneherve L, et al.
Radiat Oncol
. 2024 Dec;
19(1):175.
PMID: 39696537
Introduction: While there is a growing amount of data on the cardiac toxicity of radiotherapy (RT) in relation to its impact on cardiac sub-structures (CSS), there are only few studies...
4.
Tougeron D, Bibeau F, Chibaudel B, Kim S, Nguyen T, Phelip J, et al.
Eur J Cancer
. 2024 Nov;
213():115082.
PMID: 39486163
Aim: To evaluate R0/R1 resection rate in patients with colorectal liver metastases (CLM) treated with aflibercept plus FOLFIRI after failure of a prior oxaliplatin-based regimen in daily clinical practice. Methods:...
5.
Population-based input function (PBIF) applied to dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition
Thuillier P, Bourhis D, Pavoine M, Metges J, Le Pennec R, Schick U, et al.
Front Nucl Med
. 2024 Oct;
2:941848.
PMID: 39390995
Rational: To validate a population-based input function (PBIF) model that alleviates the need for scanning since injection time in dynamic whole-body (WBdyn) PET. Methods: Thirty-seven patients with suspected/known well-differentiated neuroendocrine...
6.
Philip P, Sahai V, Bahary N, Mahipal A, Kasi A, Rocha Lima C, et al.
J Clin Oncol
. 2024 Aug;
42(31):3692-3701.
PMID: 39088774
Purpose: Metastatic pancreatic adenocarcinoma (mPC) remains a difficult-to-treat disease. Fluorouarcil, oxaliplatin, irinotecan, and leucovorin (FFX) is a standard first-line therapy for mPC for patients with a favorable performance status and...
7.
Mansoor W, Joo S, Norquist J, Kato K, Sun J, Shah M, et al.
Oncologist
. 2024 May;
29(10):e1324-e1335.
PMID: 38815152
Background: In the KEYNOTE-590 study, first-line pembrolizumab plus chemotherapy provided statistically significant improvement in overall survival, progression-free survival, and objective response rate compared with chemotherapy, with a manageable safety profile...
8.
Thereaux J, Badic B, Fuchs B, Caillard A, Geier M, Lacut K, et al.
Ann Surg Oncol
. 2024 Mar;
31(6):3984-3994.
PMID: 38485867
Background: French policymakers recently chose to regulate high-risk digestive cancer surgery (DCS). A minimum of five cases per year should be performed for each of the following types of curative...
9.
Thereaux J, Metges J
Ann Surg Oncol
. 2024 Mar;
31(6):3663-3664.
PMID: 38472673
No abstract available.
10.
Neuzillet C, Bouche O, Tournigand C, Chibaudel B, Bauguion L, Bengrine-Lefevre L, et al.
J Natl Compr Canc Netw
. 2023 Dec;
21(12):1234-1242.e17.
PMID: 38081120
Background: The impact of adapted physical activity (APA) on health-related quality of life (HRQoL) in patients with advanced pancreatic ductal adenocarcinoma (aPDAC) is unknown. This study evaluated whether APA in...